News Releases

Targeting HIV: Moving closer to a potential cure


Tri-specific antibody targets and neutralizes 99.5% of HIV-1 virus strains

(Rockville, MD, March 13, 2018) A team of researchers at IBBR, led by Dr. Yuxing Li, Associate Professor at the University of Maryland School of Medicine, Baltimore, and Principal Investigator at the Institute for Bioscience and Biotechnology Research (IBBR), Rockville, is showing how engineered multi-specific antibodies appear to be highly effective at preventing infection across a broad range of HIV-1 virus strains.

IBBR awarded DOE grant to investigate how to protect an emerging biofuel crop from disease


UMD researchers work to defend poplar trees – a promising resource for renewable and sustainable energy – from leaf rust and other diseases

(Rockville, MD, January 29, 2018)  The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $1.1M U.S. Department of Energy grant to elucidate the mechanism of rust pathogenesis in poplar in an effort to engineer durable resistance for this important, second generation biofuel crop.  The collaborative, multidisciplinary research is led by Dr. Edward Eisenstein, IBBR Fellow and Associate Professor,... Read More

IBBR High School Intern Sarah Gao Named Regeneron Science Talent Search Finalist


Sarah Gao to Compete for Top Awards in Most Prestigious U.S. Science and Mathematics Competition for High School Seniors

(Rockville, MD., January 25, 2018) Sarah Gao, a senior at Montgomery Blair High School in Silver Spring, MD, and a research intern at the University of Maryland Institute for Bioscience and Biotechnology Research (IBBR) in Rockville, MD, has been named a finalist in the Regeneron Science Talent Search, the nation’s oldest and most prestigious science and math competition for high school seniors.

IBBR awarded NIH grant to investigate body’s T-cell mechanism of attack


New approaches hope to give researchers a glimpse into the cell’s “alert system” to fight tumors and viruses

(Rockville, MD, December 13, 2017)  A new research initiative by the Institute for Bioscience and Biotechnology Research (IBBR) and the University of Pittsburgh could finally uncover how T-cells—the “killer cells” that defend the body from microbes—are alerted to hazardous invaders in the body.  Funded by a $3.7 million grant from the National Institutes of Health (NIH), the research will be the first to combine X-ray crystallography and... Read More

IBBR Receives Grant to Explore Next Generation Multi-Specific Antibody Therapeutic: Next Step towards a Cure for HIV?


The goal is to develop and test a “first-in-class multi-specific antibody“, which could offer dramatic advantages over current treatments for AIDS patients, help eliminate hidden reservoirs of HIV, and potentially deliver on the promise of a long-awaited HIV cure.

(Rockville, MD, September 5, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $115,000 grant to further develop and commercialize a multi-specific antibody as a therapeutic for HIV.  The grant is funded under the Maryland Innovation Initiative (MII) by the Maryland... Read More

Exploring Biomedical Applications of Multifunctional Polyphosphazenes


Renowned IBBR chemist to speak at the American Chemical Society National Meeting

(Rockville, MD, August 16, 2017) Alexander K. Andrianov, Ph.D., Research Professor at the University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR), whose research led to the formation of Innovo Biopolymers LLC, is a co-organizer of a “Polyphosphazenes in Biomedicine, Engineering & Pioneering Synthesis” Symposium at the 254th American Chemical Society (ACS) Meeting, scheduled for August 20-24, 2017, in Washington, DC.  

IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine


(Rockville, MD, June 12, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant entitled, “Structure-Based Vaccine Design for Hepatitis C Virus”, to develop a novel prophylactic vaccine to prevent hepatitis C virus (HCV) infection. The grant is funded by the National Institutes of Health (NIH) and the research will take place over a five-year period.  

IBBR faculty win two Maryland Innovation Initiative (MII) grants


(Rockville, MD, June 5, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded two $115,000 grants to commercialize technologies based on improving protein-based therapeutics utilizing a novel biopolymer and an alternate way to treat Niemann-Pick disease patients. The grants are funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research and the state’s efforts to foster economic development in Maryland. 

Genisphere Begins Collaborative and Sponsored Research Program with the University of Maryland


HATFIELD, Pa - April 26, 2017 - Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration. Additional aims involve targeting diseases of the vasculature as well as inflammatory responses, demonstrating various methods of endocytosis via appropriate targeting moieties, and studying the... Read More